US 12036225
Use of ibezapolstat to promote microbiome health
granted A61KA61K31/522A61K31/5377
Quick answer
US patent 12036225 (Use of ibezapolstat to promote microbiome health) held by Acurx Pharmaceuticals, Inc. expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Acurx Pharmaceuticals, Inc.
- Grant date
- Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/522, A61K31/5377, A61P, A61P1/00